Josep Sarrà

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 253 citations · Full text

Medicine, Hematology, Oncology +17

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

Josep‐María Ribera, Albert Oriol, Marcos González et al. · Haematologica · 2009 · 190 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

Rodrigo Martino, Marı́a Dolores Caballero, José Antonio Pérez‐Simón et al. · Blood · 2002 · 179 citations · Full text

Medicine, Hematology, Immunology +16

Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma

Ibai Goicoechea, Noemí Puig, María‐Teresa Cedena et al. · Blood · 2020 · 133 citations · Full text

Medicine, Cancer Biology, Oncology +17

Allogeneic peripheral blood stem cell transplantation with reduced‐intensity conditioning: results of a prospective multicentre study

Rodrigo Martino, Marı́a Dolores Caballero, Carmen Canals et al. · British Journal of Haematology · 2001 · 112 citations

Medicine, Hematology, Immunology +11